Although soaring tuition rates are saddling aspiring doctors with what Bloomberg News called a “burgeoning debt burden,” President David Skorton said to the news outlet this month that he thinks medical school is still worth the cost. Continue reading
Tag Archives: weill-cornell
New Institute for Precision Medicine created at Weill Cornell and NewYork-Presbyterian
Public release date: 31-Jan-2013 [ | E-mail | Share ] Contact: Lauren Woods Law2014@med.cornell.edu 646-317-7401 Weill Cornell Medical College NEW YORK (Jan. 31, 2013) — Recognizing that medicine is not “one size fits all,” Weill Cornell Medical College and NewYork-Presbyterian Hospital have created the pioneering Institute for Precision Medicine at Weill Cornell and NewYork-Presbyterian/Weill Cornell Medical Center Continue reading
Weill Cornell and NewYork-Presbyterian create pioneering Institute for Precision Medicine
Recognizing that medicine is not “one size fits all,” Weill Cornell Medical College and NewYork-Presbyterian Hospital have created the pioneering Institute for Precision Medicine at Weill Cornell and NewYork-Presbyterian/Weill Cornell Medical Center. This new, cutting-edge translational medicine research hub will explore the new frontier of precision medicine, offering optimal targeted, individualized treatment based on each patient’s genetic profile. Continue reading
Damaged Heart Strengthened Using New Gene Therapy Method
January 5, 2013 redOrbit Staff & Wire Reports Your Universe Online A team of US researchers has reportedly developed a way to reprogram scar tissue from damaged hearts into healthy muscle through gene therapy a discovery which could help strengthen hearts harmed as a result of cardiovascular events. According to a recent statement, scientists from Weill Cornell Medical College, along with colleagues from the Baylor College of Medicine (BCM) and Stony Brook University Medical Center have discovered a combination of three specific genes can turn cells in the scar tissue into fully-functioning muscle cells, and the addition of a fourth can stimulate blood vessel growth and make the process even more effective. Typically, the hearts blood supply is cut off during a heart attack, causing muscles to die off and become scarred, the researchers explained Continue reading
Gene therapy reprograms scar tissue in damaged hearts into healthy heart muscle
Public release date: 4-Jan-2013 [ | E-mail | Share ] Contact: Lauren Woods Law2014@med.cornell.edu 646-317-7401 Weill Cornell Medical College NEW YORK (Jan. 4, 2013) — A cocktail of three specific genes can reprogram cells in the scars caused by heart attacks into functioning muscle cells, and the addition of a gene that stimulates the growth of blood vessels enhances that effect, said researchers from Weill Cornell Medical College, Baylor College of Medicine and Stony Brook University Medical Center in a report that appears online in the Journal of the American Heart Association Continue reading
Rebuilding Blood Vessels Through Gene Therapy
Diagnosed with severe coronary artery disease, a group of patients too ill for or not responding to other treatment options decided to take part in a clinical trial testing angiogenic gene therapy to help rebuild their damaged blood vessels. More than 10 years later, in a follow-up review of these patients, doctors at Baylor College of Medicine, Weill Cornell Medical College (where the clinical … Continue reading
Vaccine For Blocking Nicotine Chemicals Before They Reach The Brain Shows Promise
Editor’s Choice Main Category: Smoking / Quit Smoking Also Included In: Immune System / Vaccines Article Date: 02 Jul 2012 – 11:00 PDT Current ratings for: Vaccine For Blocking Nicotine Chemicals Before They Reach The Brain Shows Promise The study, published in the journal Science Translational Medicine describes that a single dose of the novel vaccine protects mice against a life-long addiction against nicotine. Continue reading
Gene therapy for smoking kills pleasure of nicotine
By Jon Bardin, Los Angeles Times / For the Booster Shots blog 7:01 p.m. EST, June 29, 2012 A new vaccine may help prevent the brain stimulation that keeps smokers from being able to quit Continue reading
Scientists invent cure to smoking… – Video
28-06-2012 04:23 I also posted a text version of my article on sacns! The Daily Telegraph is reporting on an amazing achievement… a vaccine, which causes nicotine to have no effect whatsoever… on mice Continue reading
Vaccine May Block the Effect of Nicotine
Latest Prevention & Wellness News Doctors May One Day Harness the Immune System to Help People Quit Smoking By Brenda Goodman, MA WebMD Health News Reviewed by Louise Chang, MD June 27, 2012 — Scientists say they’ve developed a vaccine that may one day protect people against the addictive effects of nicotine — but for now they have to settle for some success in mice. The vaccine uses the shell of a harmless virus that, much like the Trojan horse, carries into cells genetic instructions for making an antibody against nicotine. When cells are “infected” by the virus, they get tricked into churning out a protein that blocks nicotine’s biological effects Continue reading
New gene therapy for smoking kills the pleasure of nicotine
Cant kick cigarettes? A vaccine may one day help by preventing nicotine from reaching its target in the brain, according to research published this week. Most smoking therapies do a poor job of stopping the habit 70% to 80% of smokers who use an approved drug therapy to quit relapse. Continue reading
Vaccine stops nicotine from reaching the brain, may prevent addiction
(CBS News) Trying to quit smoking? It’s tough – studies suggest 70 to 80 percent of people who try to quit smoke within six months Continue reading
New Smoking Vaccine Using Gene Therapy Being Developed
Featured Article Academic Journal Main Category: Smoking / Quit Smoking Also Included In: Immune System / Vaccines Article Date: 28 Jun 2012 – 2:00 PDT Current ratings for: New Smoking Vaccine Using Gene Therapy Being Developed 4 (2 votes) In a study reported in the journal Science Translational Medicine this week, Researchers at Weill Cornell Medical College in New York City show how a single dose of the vaccine protected mice, over their lifetime, against nicotine addiction. The addictive properties of the nicotine in tobacco smoke is a huge barrier to success with current smoking cessation approaches, say the authors in their paper. Continue reading
Zebrafish provides insight into human melanoma
A transparent member of the minnow family is providing researchers at Weill Cornell Medical College in New York City with insight into human melanoma – a form of skin cancer – that may lead to new or repurposed drug treatments, for skin and other cancers. The experiments will be reported at the “Model Organisms to Human Biology: Cancer Genetics” Meeting, June 17-20, 2012, at the Omni Shoreham Hotel in Washington, D.C., which is sponsored by the Genetics Society of America. Continue reading
Distinct molecular subtype of prostate cancer discovered
ScienceDaily (May 20, 2012) A collaborative expedition into the deep genetics of prostate cancer has uncovered a distinct subtype of the disease, one that appears to account for up to 15 percent of all cases, say researchers at Weill Cornell Medical College, the Broad Institute of MIT and Harvard and the Dana-Farber Cancer Institute. In the study, published online May 20 by the journal Nature Genetics, investigators describe how they discovered novel mutations in the SPOP (“S-pop”) gene in numerous patient tumors, saying this alteration is thus far unique to prostate cancer and so represents a distinct molecular class that might assist in cancer diagnosis and treatment. Researchers suspect the mutations alter the way cells tag proteins for degradation, leading to an accumulation of dangerous molecules that drive the growth of cancer, perhaps from the beginning. Continue reading
Starr Foundation Continues Support for Stem Cell Research in New York with $50 Million Gift
Tri-Institutional Stem Cell Initiative Pursues Cutting-Edge Stem Cell Research and Therapies Newswise NEW YORK (April 23, 2012) — The Starr Foundation is continuing its historic commitment to stem cell research with a $50 million gift in support of the Tri-Institutional Stem Cell Initiative (Tri-SCI), which was established through a generous grant from the Foundation in 2005. The new gift, awarded to the original Tri-SCI members — Memorial Sloan-Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical College, all in New York City — will support and enhance collaborative, pioneering stem cell research at the three adjacent Manhattan campuses. With support from The Starr Foundation, Tri-SCI laboratories are investigating the properties of embryonic stem cells, which have the potential to differentiate into any cell type in the body, and adult stem cells, which are found in various tissues and can give rise to specific cell types Continue reading